Indication
Treatment of adults, adolescents and children, six years or older with diabetes mellitus, where treatment with insulin is required.
Loading your page…
Loading your page…
Diabetes Mellitus
Marketing Authorisation Holder: sanofi-aventis Deutschland GmbH
EMA Authorisation: 27/09/2004
INN: insulin glulisine
AI Drug & Interaction Analysis
Free account required
Ask Osler about Apidra: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.